27. Deutscher Krebskongress
Deutsche Krebsgesellschaft e. V.
22. - 26.03.2006, Berlin
Gastrointestinal Cancer including Liver
Meeting Abstract
(OP165)
[Volltext]
Combination of mTOR inhibitor and radiotherapy – a new strategy in multimodal therapy of malignant tumors
Manegold P, Paringer C, Kulka U, Wilkowski R, Jauch KW, Guba M, Bruns CJ[Volltext]
Meeting Abstract
(OP166)
[Volltext]
Incidence of gastrointestinal perforations (GI perf) and bleeding in patients starting bevacizumab treatment in first-line metastatic Colorectal cancer (mCRC) without primary tumour resection – Preliminary results from the First BEATrial
Kretzschmar A, Kettner E, Preiss J, Freier W, Trarbach T, Thuss-Patience P, Reichardt P, Van Cutsem E, Lutiger B, Cunningham D[Volltext]
Meeting Abstract
(OP167)
[Volltext]
Radiofrequency ablation for the treatment of liver tumors - Choice of the best approach
Schumacher G, Kunath A, Eisele R, Spinelli A, Neuhaus P[Volltext]
Meeting Abstract
(OP168)
[Volltext]
EGFR reactivates telomerase in immortalized squamous epithelial cells through PI3K/AKT-mediated phosphorylation and transcriptional regulation via Hif-1alpha
Heeg S, von Werder A, Doebele M, Quante M, Scheffer E, Goessel G, Fulda C, Kunert H, Nakagawa H, Beijersbergen R, Blum HE, Opitz OG[Volltext]
Meeting Abstract
(OP169)
[Volltext]
Combination Analysis of Activator Protein-1 Family Members, Sp1and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor (u-PAR) Gene in Resected Colorectal Cancers
Schewe D, Biller T, Maurer G, Assangani I, Leupold J, Lengyel E, Post S, Allgayer H[Volltext]
Meeting Abstract
(OP170)
[Volltext]
Loss of the „Coxsackie und Adenovirus Receptor (CAR)“ expression correlates with poor clinical outcome, tumor dedifferentiation, increased proliferation, and occurrence of distant metastasis in gastric adenocarcinomas
Anders M, Vieth M, Koschel A, Wiedenmann B, Röcken C, Ebert M, Kemmner W, Höcker M[Volltext]
Meeting Abstract
(OP171)
[Volltext]
Role of Src-family kinases in Gastrointestinal Stromal Tumors
Bauer S, Demetri GD, Fletcher JA[Volltext]
Meeting Abstract
(OP172)
[Volltext]
Development of the novel Double Enriched Nested PCR (DEN-PCR) assay for detection of K-ras Codon 12 mutations in colorectal carcinoma patients
Kraus MC, Berger MR[Volltext]
Meeting Abstract
(OP173)
[Volltext]
Final report of assessment of response to neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma patients by 18-FDG-PET
Brücher B, Wieder H, Becker K, Weiss W, Busch R, Lordick F, Stein H, Zimmermann F, Molls M, Fink U, Schwaiger M, Siewert JR[Volltext]
Meeting Abstract
(OP174)
[Volltext]
Preliminary safety of bevacizumab with first-line FOLFOX, CAPOX, FOLFIRI and Capecitabine for mCRC - First BEATrial
Kretzschmar A, Preiss J, Kettner E, Trarbach T, Richter S, Pink D, Cunningham D, Lutiger B, Van Cutsem E[Volltext]
Meeting Abstract
(OP175)
[Volltext]
Moderate-dose Radio-Chemotherapy plus Resection versus High-dose Radio-Chemotherapy alone for Locally Advanced Esophageal Cancer considering a New Prognostic Factor
Rades D, Schneider T, Yekebas EF, Muellerleile U, Gross E, Izbicki JR, Alberti W[Volltext]
Meeting Abstract
(OP176)
[Volltext]
Small bowel adenocarcinoma: cytotoxic chemotherapy for metastatic disease seemes to be more effective than commonly thought - Retrospective analysis of 39 cases
Kretzschmar A, Hofheinz RD, Stahl M, Thuss-Patience PC, Pink D, Burkart C, Mrozek A, Klima K, Reichardt P, Hartmann JT[Volltext]
Meeting Abstract
(OP177)
[Volltext]
Phase II Trial of Repeated Carcinoembryonic Antigen (CEA) Radioimmunotherapy (RAIT) with 131I-Labetuzumab Post Salvage Resection of Colorectal Liver Metastases
Liersch T, Meller J, Lorf T, Sahlmann CO, Langer C, Ghadimi BM, Wegener WA, Becker H, Goldenberg DM[Volltext]
Meeting Abstract
(PO178)
[Volltext]
Lokalrezidiv bei Rektumkarzinomen: Stellenwert der 18F-FDG PET/CT-Diagnostik
Blumstein N, Blumstein C, Messer P, Schmid I, Conzelmann A, Röttinger E, Reske SN[Volltext]
Meeting Abstract
(PO179)
[Volltext]
Weekly high-dose 5-FU as 24h-infusion and folinic acid (AIO regimen) plus Irinotecan in patients with advanced non-resectable adenocarcinoma or squamous epithelial carcinoma of the oesophagus: interim analysis of a phase II trial
Boxberger F, Wolff K, Brueckl V, Brueckl W, Meier C, Maennlein G, Horbach T, Hohenberger W, Hahn EG, Wein A[Volltext]
Meeting Abstract
(PO180)
[Volltext]
Influence of the department on the resection rate in palliative treatment of metastatic colorectal cancer (CRC)
Wein A, Liersch T, Hofheinz R, Fahlke J, Wilke J, Brueckl WM, Maennlein G, Kohnen R, Boxberger F, Hahn EG, Hohenberger W[Volltext]
Meeting Abstract
(PO181)
[Volltext]
Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis and functional gastric impairment in the animal model of Helicobacter pylori-induced carcinogenesis
Konturek PC, Brzozowski T, Konturek S, Stachura J, Hahn EG[Volltext]
Meeting Abstract
(PO182)
[Volltext]
Surgical therapy of hepatocellular carcinoma
Yedibela S, Zhang W, Meyer T, Hohenberger W[Volltext]
Meeting Abstract
(PO183)
[Volltext]
Does a negative screening colonoscopy ever need to be repeated?
Brenner H, Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister M[Volltext]
Meeting Abstract
(PO184)
[Volltext]
Factors influencing the prognosis of incidental gallbladder carcinoma
Götze T, Paolucci V[Volltext]
Meeting Abstract
(PO185)
[Volltext]
Diagnostic Value of Bile Duct Brushings Cytology in the Surveillance of Patients with Primary Sclerosing Cholangitis: A Clinical Study of 120 Patients
Al-Abadi H, Abou-Rebyeh H, Veltzke-Schliecker W, Neuhaus R, Berg T, Al-Khalili Z, Jonas S, Rösch T, Dürr A, Neuhaus P[Volltext]
Meeting Abstract
(PO186)
[Volltext]
Can Gemcitabine Improve the Treatment Results of Radiochemotherapy in Pancreatic Cancer? Results of Two Consecutive Monoinstutional Studies
Micke O, Schäfer U, Schüller P, Bruns F, DeVries A, Willich N[Volltext]
Meeting Abstract
(PO187)
[Volltext]
Use of Cell Image Analysis in the Detection of Cancer from Specimens obtained duringERC in PSC patients for screening in order to schedule patients at high risk for liver transplantation
Schmeding M, Schmeding M, Al-Abadi H, Abou-Rebyeh H, Veltzke-Schlieker W, Al-Kahlili Z, Dürr A, Neuhaus R, Berg T, Jonas S, Rösch T, Neuhaus P[Volltext]
Meeting Abstract
(PO188)
[Volltext]
Incidence of bladder outlet obstruction after rectal surgery
Zugor V, Miskovic I, Matzel K, Hohenberger W, Schott G[Volltext]
Meeting Abstract
(PO189)
[Volltext]
Identification of the gene coding for the Serine Proteinase Inhibitor kazal-type 1 (SPINK1) as the most uniform overexpressed gene in HCV-induced Hepatocarcinogenesis by genomic profiling using Oligonucleotide-MicroArrays
Hass HG, Jobst J, Nehls O, Hartmann JT, Kaiser S[Volltext]
Meeting Abstract
(PO190)
[Volltext]
HIF-1α inhibition impairs normoxic epithelial-mesenchymal transition in gastric cancer cells
Rohwer N, Vieth M, Kemmner W, Schlag PM, Cramer T, Höcker M[Volltext]
Meeting Abstract
(PO191)
[Volltext]
Epoetin alfa Improves Survival and Local Control after Chemoradiation for Stage III Esophageal Cancer: Final Results of a Prospective Study
Rades D, Tribius S, Yekebas EF, Muellerleile U, Gross E, Schild SE, Izbicki JR, Alberti W[Volltext]
Meeting Abstract
(PO192)
[Volltext]
Incidence of erectile dysfunctions after rectal operations
Zugor V, Miskovic I, Matzel K, Hohenberger W, Schott G[Volltext]
Meeting Abstract
(PO193)
[Volltext]
Prognostic significance of local macroscopic and microscopic tumor factors at multimodality treated pancreatic patients
Wilkowski R, Bruns C, Diebold J, Heinemann V[Volltext]
Meeting Abstract
(PO194)
[Volltext]
Safety of anemia-therapy with erythropoietin-alfa during neoadjuvant platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma.
Abbrederis K, Bassermann F, Schuhmacher C, Voelter V, Busch R, Röthling N, Siewert JR, Peschel C, Lordick F[Volltext]
Meeting Abstract
(PO195)
[Volltext]
Inhibition of Barrett's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins
Konturek PC, Burnat G, Hahn EG, Raithel M[Volltext]
Meeting Abstract
(PO196)
[Volltext]
Risk reduction of colorectal cancer with long-term use of low-dose aspirin and nonsteroidal anti-inflammatory drugs
Hoffmeister M, Chang-Claude J, Brenner H[Volltext]
Meeting Abstract
(PO197)
[Volltext]
Results of secondary resection after responding to chemotherapy and reaching operability after primarily inoperable gastric cancer
Fahlke J, Schmidt C, Stübs P, Hribaschek A, Schmidt S, Zierau K, Schulz HU, Lippert H[Volltext]
Meeting Abstract
(PO198)
[Volltext]
Combination of mTOR inhibitor and radiotherapy – a new strategy in multimodal therapy of malignant tumors
Manegold P, Paringer C, Kulka U, Wilkowski R, Jauch KW, Guba M, Bruns CJ[Volltext]
Meeting Abstract
(PO199)
[Volltext]
Expression of cathepsin B in gastric adenocarcinomas represents a prognostic marker
Baldus SE, Mönig SP, Nolte S, Grass G, Bollschweiler E, Hölscher AH, Dienes HP[Volltext]
Meeting Abstract
(PO200)
[Volltext]
Metastatic Gastroenteropancreatic Neuroendocrine Tumors: The Revised WHO Classification and its Correlation with Somatostatin Analog Uptake
Ezziddin S, Yong-Hing C, Ahmadzadehfar H, Fischer HP, Habibi E, Leifeld L, Biersack HJ[Volltext]
Meeting Abstract
(PO201)
[Volltext]
Helicobacter pylori controls serine and tyrosine phosphorylation of cortactin to induce actin cytoskeletal rearrangements and host cell scattering
Wittelsberger R, Meyer F, Brandt S, Tegtmeyer N, König W, Backert S[Volltext]
Meeting Abstract
(PO202)
[Volltext]
Prediction of response to chemotherapy using 18-fluorodeoxyglucose positron emission tomography in advanced oesophageal and gastric cancer
Lorenzen S, Herrmann K, Wieder H, Hennig M, Bredenkamp R, Peschel C, Schwaiger M, Lordick F[Volltext]
Meeting Abstract
(PO203)
[Volltext]
Ki-67 Auto-Antibodies of Colorectal Cancer Patients
Duchrow M, Ziems C, Broll R, Habermann JK, Roblick UJ, Bruch HP[Volltext]
Meeting Abstract
(PO204)
[Volltext]
Significance of acetone treatment for lymph node preparation and staging in colorectal specimens
Richter D, Lorenz D, Fisseler-Eckhoff A[Volltext]
Meeting Abstract
(PO205)
[Volltext]
Preoperative hospital information program for cancer patients in surgery and their relatives: First results
Berend M, Teren K, Küchler T, Kremer B[Volltext]
Meeting Abstract
(PO206)
[Volltext]
Hox- and MMP- gene family members are expressed in freshly frozen and paraffin embedded metastatic colorectal carcinoma – implication for response prediction to a palliative 5-FU containing chemotherapy
Brueckl WM, Wirtz R, Croner RS, Boxberger F, Gentner B, Schuppert A, Meyer T, Papadopoulos T, Hahn EG, Hohenberger W, Wein A[Volltext]
Meeting Abstract
(PO207)
[Volltext]
PD-1/PD-L1 expression in colorectal cancer and its implications for apoptosis and tumor immune evasion
Gasser M, Grimm M, Nichiporuk E, Bueter M, Lebedeva T, Lutz J, Koenigshausen M, Thalheimer A, Thiede A, Heemann U, Meyer D, Waaga-Gasser AM[Volltext]
Meeting Abstract
(PO208)
[Volltext]
Combination of radiofrequency (RF) ablation and systemic chemotherapy for colorectal liver metastases: A prospective phase II study
Burkart C, Hartmann JT, Bitzer M, Käfer G, Clasen S, Kanz L, Pereira P[Volltext]
Meeting Abstract
(PO209)
[Volltext]
Improvements of prognosis of gastrointestinal tumours: results of the Munich Cancer Registry
Engel J, Hölscher G, Eckel R, Schubert-Fritschle G, Hölzel D[Volltext]
Meeting Abstract
(PO210)
[Volltext]
Socio-economic status and gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)
Nagel G, Linseisen J, Del Giudice G, González CA, Riboli E[Volltext]
Meeting Abstract
(PO211)
[Volltext]
Bolus MIT Tomycin C in Combination with Protracted Infusional 5-Flurouracil/Folinic Acid in Pretreated Patients with Advanced Gastric Adenocarcinoma: Results of an Extended Phase II Study
Hartmann JT, Quietzsch D, Al-Batran SE, Pintoffl J, Nehls O, Käfer G, Burkart C, Kanz L[Volltext]
Meeting Abstract
(PO212)
[Volltext]
Inhibition of telomerase by mutant template telomerase RNA and anti-telomerase short interfering RNA induces ALT in immortalized human esophageal epithelial cells.
Döbele M, von Werder A, Fulda C, Heeg S, Gössel G, Quante M, Harada H, Suliman Y, Li S, Blackburn EH, Blum HE, Opitz OG[Volltext]
Meeting Abstract
(PO213)
[Volltext]
CONKO-101: Erste Ergebnisse einer offenen Phase II Studie mit Gemcitabin, 5-FU (24h), Folinsäure und Cisplatin bei Patienten mit inoperablem Ösophaguskarzinom
Stieler J, Hilbig A, Pelzer U, Roll L, Dörken B, Riess H, Oettle H[Volltext]
Meeting Abstract
(PO214)
[Volltext]
Peculiarities of Gastric Carcinomas in Patients under 50 Years of Age
Schildberg C, Merkel S, Dimmler A, Horbach T, Hohenberger W[Volltext]
Meeting Abstract
(PO215)
[Volltext]
Surgical endoscopy compared to non-surgical endoscopy in patients with esophageal cancer. Is it any better?
Colombo-Benkmann M, Vowinkel T, Palmes D, Tübergen D, Brüwer M, Senninger N[Volltext]
Meeting Abstract
(PO216)
[Volltext]
Bile salts induce COX-2 expression in Barrett adenocarcinoma cells via stimulation of NFkappaB
Konturek PC, Burnat G, Hahn EG[Volltext]
Meeting Abstract
(PO217)
[Volltext]
Significance of the anti-inflammatory factor hemeoxgenase-1 (HO-1) for the function of tumour infiltrating macrophages
Benckert C, Rohwer N, Cramer T, Spinelli A, Neuhaus P, Jonas S[Volltext]
Meeting Abstract
(PE218)
[Volltext]
Chemotherapy-induced long-term complete remission of the primary in patients with stage IV colorectal cancer. Report of three consecutive cases
Güldenzoph B, Armbrust T, Ramadori G[Volltext]
Meeting Abstract
(PE219)
[Volltext]
Transanal endoscopic microsurgery (TEM) and radiochemotherapy (RCT) in early rectal cancer
Zimmermann F, Riedl W, Molls M, Bues G[Volltext]
Meeting Abstract
(PE220)
[Volltext]
Association of CPT-11 pharmacokinetics and non-hematological toxicity in patients with advanced gastrointestinal cancer and influence of age
Merkel U, Farker K, Rückert M, Wedding U, Hippius M, Höffken K, Hoffmann A[Volltext]
Meeting Abstract
(PE221)
[Volltext]
New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness
Haug U, Brenner H[Volltext]
Meeting Abstract
(PE222)
[Volltext]
Chemokine receptors CXCR4 and CCR7 influence proliferation and dissemination of human hepatocellular cancer
Schimanski CC, Bahre R, Teufel A, Simiantonaki N, Wilsberg V, Wehler T, Achenbach T, Galle PR, Moehler M[Volltext]
Meeting Abstract
(PE223)
[Volltext]
Outcome of patients with colorectal cancer and synchronous metastases (UICC IV)
Gog C, Pession U, Sachs M, Bechstein WO[Volltext]
Meeting Abstract
(PE224)
[Volltext]
Lymphatic vessel density in pancreatic carcinoma
Assmann G, KLEESPIES A, Nolte A, Wilkowski R, Bruns C, Diebold J[Volltext]
Meeting Abstract
(PE225)
[Volltext]
Small cell cancer of the anal canal – Report of a rare case
Meyer A, Bruns F, Richter K, Grünwald V, Karstens JH[Volltext]
Meeting Abstract
(PE226)
[Volltext]
Health economic evaluation of a newly developed oxaliplatin solution in comparison to the conventional lyophilisate
Sievert M, Deuß B, Frick M, Rosenfeld S[Volltext]
Meeting Abstract
(PE227)
[Volltext]
The Rap1/B-Raf signaling complex is a putative therapeutic target in neuroendocrine tumors of the digestive tract
Schrader J, Hörsch D, Arnold R[Volltext]
Meeting Abstract
(PE228)
[Volltext]
5-FU/FA/Mitomycin as second to fourth-line chemotherapy in patients with advanced colorectal cancer: A retrospective analysis
Güse-Gocht K, Klose G, Ramsauer B, van de Loo I, Spehn J[Volltext]
Meeting Abstract
(PE229)
[Volltext]
Single-nucleotide polymorphism (SNP) of ABCB1 transporter in colorectal cancer patients and relation to the pharmacokinetics of irinotecan
Farker K, Merkel U, Wedding U, Hippius M, Höffken K, Hoffmann A[Volltext]
Meeting Abstract
(PE230)
[Volltext]
Proteasominhibitoren sensitivieren HCC Zellinien aber nicht primäre humane Hepatozyten für TRAIL-induzierte Apoptose durch verstärkte Caspase-8 Rekrutierung am DISC unabhängig von NF-kB
Ganten T, Ganten TM, Koschny R, Sykora J, Haas T, Fas S, Stremmel W, Walzcak H[Volltext]
Meeting Abstract
(PE231)
[Volltext]
Docetaxel as salvage therapy in highly pretreated and chemo-resistant gastrointestinal tumors
Sprinzl M, Schleef S, Dahmen A, Galle P, Kanzler S, Moehler M[Volltext]
Meeting Abstract
(PE232)
[Volltext]
Metastatic Colon Cancer in pregnancy: a treatment concept
Himsl I, Lenhard M, von Koch F, Wichmann M, Schulze A, Hasbargen U, Friese K[Volltext]
Meeting Abstract
(PE233)
[Volltext]
Prospective evaluation of novel tests for early detection of colorectal cancer (BLITZ-Study)
Haug U, Koßmehl S, Sieg A, Brenner H[Volltext]
Meeting Abstract
(PE234)
[Volltext]
First line therapy of metastatic colon cancer with 5-FU, folinic acid and bevacizumab in chronic renal failure: Complete remission in a patient with advanced colon cancer undergoing hemodialysis
Jochims C, Ring A, Stremmel W, Jäger D, Herrmann T[Volltext]
Meeting Abstract
(PE235)
[Volltext]
Irinotecan/Capecitabine versus Cisplatin/Capecitabine in Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction: Preliminary Results of a Randomized German AIO Phase II-Study
Möhler M, Geissler M, Kanzler H, Raedle J, Malfertheiner P, Fischbach W, Scheruebl H, Seufferlein T, Galle PR, Hoehler T[Volltext]
Meeting Abstract
(PE236)
[Volltext]
Cholangiocellular carcinoma responding on Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) – A Case Report
Sprinzl M, Schimanski C, Galle P, Moehler M, Kanzler S[Volltext]
Meeting Abstract
(PE237)
[Volltext]
Case reports: Treatment of progressive, metastatic, non functioning neuroendocrine tumours (NET) with Octreotide
Gog C, Pession U, Wullstein C, Bechstein WO[Volltext]
Meeting Abstract
(PE238)
[Volltext]
Comparative analysis of prognostic factors of Adeno (AC)- and squamous cell cancer (SCC) of the esophagus
Colombo-Benkmann M, Meyer B, Brüwer M, Senninger N[Volltext]
